Maternal immune activation virus related and schizophrenia
Psychiatria Danubina · 17.11.2026 · 38 (3) · 241
DOI: 10.24869/psyd.2026.241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychiatria Danubina, online erschienen am 17.11.2026. Verfasst von Antonino Messina und 1 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Maternal immune activation (MIA) refers to the activation of the mother’s immune system during pregnancy, which can have implications for the developing fetus. There is evidence suggesting that maternal immune activation, particularly due to viral infections during pregnancy, may increase the risk of certain neurodevelopmental disorders such as schizophrenia in the offspring. Research in this area has shown that exposure to certain viruses during pregnancy, such as herpes simplex, Zika, and influenza virus may contribute to alterations in fetal brain development, potentially leading to an increased risk of schizophrenia later in life. The exact mechanisms through which this occurs are still being investigated, but it’s believed that the maternal immune response to the viral infection, including the release of inflammatory molecules called cytokines, may play a role in disrupting normal brain development. In this review of the literature on MIA and schizophrenia we will describe the potential implications of the findings from animal studies, epidemiological investigations, and clinical research to provide a preliminary understanding of this relationship.
Zitieren
APA
Messina, A., & Signorelli, M. S. (2026). Maternal immune activation virus related and schizophrenia. Psychiatria Danubina, 38(3), 241. https://doi.org/10.24869/psyd.2026.241
Vancouver
Messina A, Signorelli MS. Maternal immune activation virus related and schizophrenia. Psychiatria Danubina. 2026;38(3):241. doi:10.24869/psyd.2026.241
BibTeX
@article{Messina2026,
author = {Messina, Antonino and Signorelli, Maria Salvina},
title = {Maternal immune activation virus related and schizophrenia},
journal = {Psychiatria Danubina},
year = {2026},
volume = {38},
number = {3},
pages = {241},
doi = {10.24869/psyd.2026.241}
}
EUVIMED